Back

Medtronic PLC

Ticker: MDT ISIN: IE00BTN1Y115
Add to portfolio Portfolio analysis in 2min
Stock Large-cap Dividend payer
Market cap
$100.09B
P/E
21.78
Forward P/E
12.76
Profit margin
13.00%
Revenue growth QoQ
8.70%
Div. yield
3.65%
Beta
0.63
$92.90 -0.48%
Price as of 2026-08-24 · NYSE

Performance by timeframe

Rolling returns
1 Month +10.31%
6 Months -2.32%
1 Year +4.22%
5 Years -4.02% p.a.-18.53%
10 Years +3.32% p.a.+38.61%
Since inception +4.95% p.a.+234.33%
Calendar year returns
YTD -1.62%
2025 +24.05%
2024 +0.28%
2023 +9.58%
2022 -22.55%
2021 -9.79%

Key stats

Market cap
100.09B
P/E
21.78
Dividend yield
3.65%
Beta
0.63
52-week range
75.91 - 104.70
50-day MA
86.76
200-day MA
93.91
Section 1

Business overview

Company profile data from fundamentals.

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Sector Healthcare
Industry Medical Devices
Country Ireland
Exchange NYSE
Section 2

Financial quality

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 9.39%
ROA 4.57%
Profit margin 13.00%
Operating margin 20.01%
PEG ratio 1.36
Revenue/share TTM 27.68
Revenue TTM 35.48B
EBITDA 9.44B
Gross profit TTM 23.12B
Beta 0.63

Valuation

Trailing P/E 21.78
Forward P/E 12.76
P/B 2.04
P/S 2.82
EV/EBITDA 12.78
EV/Revenue 3.37

ESG Scores

Total ESG 26.9
Environment 4.1
Social 15.3
Governance 9.0
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 5.53
Quarterly earnings growth -11.80%
Revenue TTM 35.48B
Reported quarters 121
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Dividend yield 3.65%
Forward annual div. yield 2.83%
Dividend per share 2.8300
Payout ratio 50.27%
Ex-dividend date 2025-12-26
Split factor 2:1
Last split date 1999-09-27
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price $110.97
Analyst rating 3.8125

Ownership & short interest

Shares outstanding 1.28B
Shares float 1.28B
Institutional ownership 88.43%
Insider ownership 29.40%
Short ratio 1.96
Short % of float 1.21%

Details

Instrument metadata and source update timestamps.

Symbol MDT
Name Medtronic PLC
Asset type STOCK
Exchange NYSE
Currency USD
ISIN IE00BTN1Y115
Country USA
Code + exchange MDT.NYSE
Last price date 2026-05-08
Fundamentals updated 2026-05-08

The information provided on this platform is for informational purposes only and should not be considered as financial or investment advice. Insightfolio does not provide investment advice, personalized recommendations, or guidance regarding the purchase, holding, or sale of financial assets. The tools and content are intended for educational purposes only and are not tailored to individual circumstances, financial needs, or objectives.

Insightfolio assumes no liability for the accuracy, completeness, or reliability of the information presented. Users are solely responsible for verifying the information and making independent decisions based on their own research and careful consideration. Use of the platform should not replace consultation with qualified financial professionals.

Investments involve risks. Users should be aware that the value of investments may fluctuate and that past performance is not an indicator of future results. Investment decisions should be based on personal financial goals, risk tolerance, and independent evaluation of relevant information.

Insightfolio does not endorse or guarantee the suitability of any particular financial product, security, or strategy. Any projections, forecasts, or hypothetical scenarios presented on the platform are for illustrative purposes only and are not guarantees of future outcomes.

By accessing the services, information, or content offered by Insightfolio, users acknowledge and agree to these terms of the disclaimer. If you do not agree to these terms, please do not use our platform.

Instrument logos provided by Elbstream.